Global drug diffusion and innovation with the medicines patent pool
Summary. The Medicines Patent Pool, a joint licensing platform for patented drugs, significantly increases generic drug supply in developing countries, especially those with stronger patent protection. The pool enables generic firms worldwide to license drug bundles affordably for sales in designated developing nations. Analysis of licensing contracts, procurement data, clinical trials, and drug approvals shows the pool also generates modest increases in clinical trials and new drug approvals, primarily from non-pool firms.
Cite this article
Wang, L. X.. (2022). Global drug diffusion and innovation with the medicines patent pool. Journal of Health Economics. https://doi.org/10.1016/j.jhealeco.2022.102671
Wang, Lucy Xiaolu. “Global drug diffusion and innovation with the medicines patent pool.” Journal of Health Economics, 2022. https://doi.org/10.1016/j.jhealeco.2022.102671.
Wang, Lucy Xiaolu. 2022. “Global drug diffusion and innovation with the medicines patent pool.” Journal of Health Economics. https://doi.org/10.1016/j.jhealeco.2022.102671.
@article{wang-2022-global-drug-diffusion-innovation-medicines,
title = {Global drug diffusion and innovation with the medicines patent pool},
author = {Lucy Xiaolu Wang},
journal = {Journal of Health Economics},
year = {2022},
doi = {10.1016/j.jhealeco.2022.102671},
url = {https://doi.org/10.1016/j.jhealeco.2022.102671}
}
TY - JOUR TI - Global drug diffusion and innovation with the medicines patent pool AU - Lucy Xiaolu Wang JO - Journal of Health Economics PY - 2022 DO - 10.1016/j.jhealeco.2022.102671 UR - https://doi.org/10.1016/j.jhealeco.2022.102671 ER -
Details
- DOI
- 10.1016/j.jhealeco.2022.102671
- Countries
- Canada, United States, Germany
- Regions
- North America, Europe
- Categories
- policy, innovation-networks, general-innovation
- Added
- 2026-04-28